CanSino Biologics, Inc. (CASBF)
4.90
+0.25
(+5.32%)
USD |
OTCM |
Oct 06, 16:00
CanSino Biologics EPS Diluted (Quarterly) : 0.0236 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0236 |
| March 31, 2026 | -0.0236 |
| December 31, 2025 | 0.0077 |
| September 30, 2025 | 0.0158 |
| June 30, 2025 | -0.0011 |
| March 31, 2025 | -0.0064 |
| December 31, 2024 | -0.088 |
| September 30, 2024 | 0.0017 |
| June 30, 2024 | -0.0309 |
| March 31, 2024 | -0.0957 |
| December 31, 2023 | -0.2785 |
| September 30, 2023 | -0.0802 |
| June 30, 2023 | -0.405 |
| March 31, 2023 | -0.0827 |
| December 31, 2022 | -0.2477 |
| September 30, 2022 | -0.2876 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.0669 |
| March 31, 2022 | 0.0774 |
| December 31, 2021 | 0.3669 |
| September 30, 2021 | 0.2479 |
| June 30, 2021 | 0.595 |
| March 31, 2021 | -0.0088 |
| December 31, 2020 | -0.1346 |
| September 30, 2020 | -0.0462 |
| June 30, 2020 | -0.0451 |
| March 31, 2020 | -0.0134 |
| December 31, 2019 | -0.0363 |
| September 30, 2019 | -0.0137 |
| June 30, 2019 | -0.0145 |
| March 31, 2019 | -0.0271 |
| June 30, 2018 | -0.0242 |
| June 30, 2017 | -0.0101 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.833M |
| Revenue (Quarterly) | 52.82M |
| Total Expenses (Quarterly) | 46.99M |
| Enterprise Value | 1.083B |
| Gross Profit Margin (Quarterly) | 67.99% |
| Profit Margin (Quarterly) | 11.04% |
| Earnings Yield | 0.48% |
| Normalized Earnings Yield | 0.349 |